A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma

scientific article published on 24 February 2011

A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1634/THEONCOLOGIST.2010-0223
P932PMC publication ID3228108
P698PubMed publication ID21349948
P5875ResearchGate publication ID50196003

P2093author name stringDavid P Ryan
Andrew X Zhu
Jeffrey W Clark
Dorcas Chi
Hejing Wang
Kathy P Theall
Olga N Kozyreva
P2860cites workHepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.Q37157400
Hepatic resection for hepatocellular carcinoma in the elderlyQ44538626
Hepatic resection for hepatocellular carcinoma in the elderlyQ44795211
Risk factors for hepatocellular carcinoma in patients with cirrhosisQ44903654
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomyQ45010628
Optimal treatment strategy for elderly patients with hepatocellular carcinomaQ45204378
Age-related comparison of the profiles of patients with hepatocellular carcinoma.Q51774279
Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis.Q53416462
Unintentional poisoning deaths--United States, 1999-2004.Q55043118
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experienceQ56989067
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderlyQ63245401
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosisQ79915940
Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patientsQ82950888
[Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years]Q83139210
Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinomaQ83844066
A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 yearsQ84316995
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical managementQ93926292
Understanding the attitudes of the elderly towards enrolment into cancer clinical trialsQ25257182
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the LiverQ29616866
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Prognosis of hepatocellular carcinoma: the BCLC staging classificationQ29619984
Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survivalQ33829856
Geriatric oncology: challenges for the new centuryQ34023948
Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.Q34507415
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohortQ34556277
Hepatocellular carcinoma: recent trends in the United StatesQ35929212
Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 yearsQ36079732
Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?Q36503071
Older female cancer patients: importance, causes, and consequences of undertreatmentQ36815538
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseQ37112127
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmulticenter clinical trialQ6934595
P304page(s)310-318
P577publication date2011-02-24
P1433published inOncologistQ2122327
P1476titleA multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma
P478volume16

Reverse relations

cites work (P2860)
Q33606153350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy
Q42262211Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China
Q38723572Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection
Q92200691Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study
Q35915306Factors associated with the overall survival of elderly patients with hepatocellular carcinoma
Q30234460Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses
Q36950854Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities
Q34525541Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma
Q37184472Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States
Q89528234New landscapes and horizons in hepatocellular carcinoma therapy
Q44821007Old age and forgoing treatment: a nationwide mortality follow-back study in the Netherlands
Q53009874Small cell lung carcinoma mimicking hepatocellular carcinoma with direct invasion into the inferior vena cava and through the right hemidiaphragm in an elderly adult.
Q48294520Sorafenib in elderly patients with advanced hepatocellular carcinoma: a case series
Q40277662Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation
Q53095390Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.
Q36821641Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma